BusinessWire - Bristol-Myers Squibb Company (BMY) Bristol-Myers Squibb Announces Dividend

BMY Bristol-Myers Squibb Company

Bristol-Myers Squibb Announces Dividend

NEW YORK--(BUSINESS WIRE)--

The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of thirty-nine cents ($0.39) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on August 1, 2017, to stockholders of record at the close of business on July 7, 2017.

The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable September 1, 2017 to stockholders of record at the close of business on August 8, 2017.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, and YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170613006069/en/

13/06/2017

Underlying

BMYBristol-Myers Squibb Company

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bristol-Myers Squibb Company

Free Trial

BMY Bristol-Myers S...

Bristol Myers Squibb Co: 1 director

A director at Bristol Myers Squibb Co sold 30,000 shares at 61.667USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...